Custom Formulation vs Private Label Supplements

What is the actual difference?

When is private label the right answer?

More often than founder culture admits. Private label is the right call when:

• You are testing whether a channel or an audience responds at all, and the formula is not the variable you are testing.
• The category is genuinely commoditised — a single-ingredient product where the specification is the specification and there is nothing to differentiate.
• Speed to shelf is the binding constraint, because a window is closing or a partnership requires product now.
• Your budget cannot absorb development plus a first production run, and proving demand has to come first.
• The product is a line extension whose job is basket size rather than positioning.

What makes private label a mistake is not the model. It is using it for the product your brand is supposed to be known for, and discovering two years in that the thing customers buy you for is something they can buy from four other labels, and that leaving your supplier means reformulating from scratch.

What does custom actually buy you?

A formula you can defend

A custom composition is something you can make claims about, run evidence against, and protect. It is also the only version of this that supports a novelty position — you cannot claim a differentiated mechanism for a formula available under four other brand names.

Supplier mobility

This is the underrated one. If you own the formula and the master batch record, a manufacturer who raises prices, misses lead times, or fails an audit is a manufacturer you can replace. If the supplier owns the formula, they are not a vendor, they are a dependency, and every commercial conversation happens on their terms.

An asset on the balance sheet

Formula IP, and the evidence package behind it, is a thing an acquirer or an investor can value. A private-label listing is a distribution position, which is worth something quite different and is considerably easier to compete away.

Claims tied to your composition

Structure-function claims have to be supported by the product you are actually selling. A custom formula lets you build the evidence around your specific actives and doses. A stock formula limits you to whatever the supplier's documentation already supports, which may be less than the marketing you had in mind.

The semi-custom trap

Most suppliers who offer private label also offer to modify a stock base, and this is where founders most often believe they have bought something they have not. Adding two actives to a supplier's base does not usually make the resulting formula yours. It makes it the supplier's base with your additions, and the ownership terms vary enormously.

Read the agreement for these specifically:

• Who owns the modified formula — explicitly, in writing, not by implication.
• Whether the supplier can sell the modified version, or anything materially similar, to another brand.
• Whether you can take the modified formula to another manufacturer, and what you would be entitled to receive if you did.
• Who owns the master batch record and the supporting documentation.
• What happens to all of the above if you stop ordering.

A supplier who answers these clearly is a good partner regardless of which model you pick. A supplier who deflects them has told you the answer.

How Formulaite changes the calculation

The historical reason to accept private label was that custom formulation required an in-house R&D function or a long, expensive development contract with a lab. That is the constraint the model was built around.

Formulaite compresses the development side: you describe the product, and the AI R&D agent produces an evidence-based formula with actives, doses, citations, and regulatory screening, in hours rather than months. Simulation models how the actives behave before any lab spend. The output is a manufacturer-ready package — brief and master batch record — that you own outright, and it goes to vetted contract manufacturers matched on format and volume. That does not make custom free, but it moves the decision away from "can we afford development at all" and toward the question that should have been driving it: do you want to own this or rent it.

Frequently asked questions

Can I start private label and move to custom later?

Yes, and it is a reasonable sequence — prove the demand, then own the product. Plan for the transition rather than assuming it: your customers know the current formula, so a reformulation is a product change you have to manage, and reviews attach to the listing rather than the composition. Starting the custom development while private label is still selling is usually smoother than stopping to do it.

Is private label lower quality than custom?

Not inherently. Quality is set by the facility, the raw materials, and the testing regime, all of which can be excellent on a stock formula and poor on a custom one. What private label costs you is differentiation and ownership, not necessarily quality. Vet the facility on the same criteria either way.

How much of a formula do I have to change before it is mine?

There is no percentage threshold that settles it — ownership is determined by the agreement you signed, not by how different the formula is. A heavily modified stock base can still belong to the supplier if the contract says so, and a lightly modified one can belong to you if it says that instead. Read the agreement rather than reasoning about the formula.

Does owning the formula mean I can patent it?

Ownership and patentability are separate questions. Owning a formula means you control it, can move it between manufacturers, and can build claims on it. Patentability requires novelty and non-obviousness, which most combinations of known botanical actives will not meet. Formulaite includes a novelty assessment so you know which of the two you actually have before you spend money finding out.

Related founder resources